About Us

Goals of the D43

This training grant, funded by the National Institutes of Health (NIH), aims to maximize the rigor of cancer research in sub-Saharan Africa (SSA) by training researchers to develop the strategic and operational capacity that will generate new knowledge about the determinants of cancer risk and outcomes and by improving the effectiveness of strategies for reducing risk and improving outcomes.

The overarching goals of this training program are to:

  • Develop and disseminate best practices to enable the highest quality cancer research in Africa
  • Teach fundamental skills to those who conduct research in Africa
  • Create a cadre of individuals to lead and support cancer research in SSA

The specific aims are to:

  • Develop and implement an educational and career development program that will maximize the rigor of cancer research being conducted in SSA
  • Recruit and train individuals who can build sustainable careers in cancer research
  • Assess the impact of this training program on the career outcomes of trainees and participants
Dr. Timothy R Rebbeck is the Vincent L. Gregory, Jr. Professor of Cancer Prevention at the Harvard TH Chan School of Public Health and Professor of Medical Oncology at the Dana-Farber Cancer Institute, Boston, USA
Dr. Yuri Quintana is Chief of the Division of Clinical Informatics, BIDMC, and Assistant Professor of Medicine at the Harvard Medical School, Boston, USA.
Dr. Elima Jedy-Agba is a Research Scientist at the Institute of Human Virology, Abuja, Nigeria.
Dr. Mohamed Jalloh is a urologist and consultant at the Hôpital Général Idrissa Pouye, Dakar, Senegal.
Emeka Odiaka is a licensed Project Management Professional at the University College Hospital, Ibadan, Nigeria with experience in administration, human resource management,and project management.
Caroline Andrews is a Sr. Research Project Manager, at the Dana-Farber Cancer Institute, Boston, USA with experience in project coordination, clinical research, database design and ensuring ethics compliance.